Our Leadership and Advisory Team
Young Shen, PhD
Founder, CEO
Medicinal Chemist, 27 years’ natural product drug discovery experience. Developed anticancer drug, Halaven, at Eisai
John Liu, PhD
Co-Founder, VP
Molecular and Cell Biologist, more than 30 years’ drug discovery experience at Harvard Medical School and Eisai
Benedict Kolber, PhD
CSO
17 years’ experience in preclinical and clinical pain research, Associate Professor of Neurobiology at UT Dallas
Powen Hsu, MD
Clinical Advisor
Pain Specialist and Medical Director at Fusion Health Services, 37 years’ experience in treating pain
William Christ, PhD
Scientific Advisor
Natural product and process research expert, Executive Vice President at Eisai, CSO at 3 drug companies
John Zhang, PhD, MD
Toxicology Advisor
Board-certified toxicologist with 27 years’ experience, Executive VP at Ark Biosciences, VP at 2 drug companies